Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions

Area of Science:

• Oncology
• Gastroenterology
• Cancer Biology

Background:

• Colorectal cancer (CRC) liver metastases present challenges in early detection, prognosis, and treatment selection.
• Despite therapeutic advances, significant improvements are needed in tailoring treatments for maximum patient benefit.
• Recent progress includes identifying high-risk cohorts, understanding drug delivery, developing liquid biomarkers, and advances in immunotherapy.

Purpose of the Study:

• To review current challenges and recent advances in managing colorectal cancer liver metastases.
• To discuss gene signatures, regional/systemic therapies, tumor microenvironment insights, and noninvasive biomarkers.
• To highlight the need for refined predictive/prognostic studies and a multidisciplinary approach.

Main Methods:

• State-of-the-science symposium to discuss current research and clinical challenges.
• Review of existing literature on gene signatures, therapeutic strategies, and biomarkers.
• Synthesis of multidisciplinary expert perspectives on colorectal cancer liver metastases.

Main Results:

• Discussion of discrete gene signatures correlating with prognosis in CRC liver metastases.
• Review of strategies to enhance regional and systemic therapies for decreasing intrahepatic recurrence.
• Summary of advancements in understanding the tumor microenvironment and noninvasive multimodal biomarkers.

Conclusions:

• Continued refinement of predictive and prognostic studies is crucial for decreasing recurrence after resection.
• Minimizing treatment toxicity through a tailored, multidisciplinary approach is essential for patient care.
• Integrating new biomarkers and therapeutic strategies promises improved outcomes for CRC liver metastases.